Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Objective The aim of this retrospective study was to compare clinical, biological, and histological features and treatment response in 115 patients with overlap syndrome (OS), autoimmune hepatitis (AIH) or primary biliary cirrhosis (PBC).Methods Consecutive patients with AIH, PBC or OS followed between 1984 and 2005 in five different centers were included. All data were re-evaluated using current diagnostic criteria of each disease.Results Fifteen patients had OS (13 females), 48 AIH (40 females) and 52 PBC (49 females). Patients with OS were significantly younger than patients with PBC (median age: 44 vs 59 years). Jaundice (20%) and pruritus (20%) were the main initial symptoms in OS. Patients with OS had serum transaminase and gammaglobulin levels significantly higher than patients with PBC; serum alkaline phosphatase, gamma-glutamyl-transpeptidase and IgM levels were significantly higher in OS than in patients with AIH. Histological analysis showed moderate or severe piecemeal necrosis in 86% and destructive cholangitis in 93% in OS group. Among 11 patients with OS treated with ursodeoxycholic acid (UDCA) or immunosuppressors alone, only 6 had a complete biochemical response. In contrast, all patients with OS receiving combined therapy, as first or second line, responded, 5 patients to the combination corticosteroids-azathioprine-UDCA and 2 to the combination cyclosporine-UDCA.Conclusion OS is not rare and accounts for 13.9% of patients with autoimmune liver disease in our series. Combination of immunosuppressors and UDCA appears the most efficient treatment in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These criteria have been met in 1% to 14.2% of PBC patients, with higher rates found in Hispanic PBC patients.(128)(129)(130)(131)(132)(133)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [130]
In the citing paper
“UDCA with or without immunosuppressive therapy has been used, but no clear consensus on optimal therapy for these patients exists.(129)(130)(134)(135)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [130]
Citations
Cites
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 753
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Hepatology. A Textbook of Liver Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-259_2 · Cited by 621
Symposium: Advances in Liver Pathology [Abridged]: Primary Biliary Cirrhosis
Scheuer, P. J. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706001205 · Cited by 557
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
Research works printed but not linked: 2
- Labayle, 1980, Hépatite chronique active ou cirrhose biliaire primitive. A propos de cinq observations, Gastroenterol Clin Biol, 4, 848
- Ganne-Carrié, 1998, Hépatites d’allure auto-immune induites par les fibrates, Gastroenterol Clin Biol, 22, 525
Cited by
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
“With no codified diagnostic approach, reported prevalence figures are variable, but it is generally assumed that the prevalence of AIH-PBC variant is approximately 8–10% of adult patients with either PBC or AIH [57,58].”
BackgroundLindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Boberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
Sucher, E., Sucher, R., Gradistanac, T., Brandacher, G., Schneeberger, S., & Berg, T. (2019) · Journal of Immunology Research · doi:10.1155/2019/9437043 · Cited by 170
Metadata
- Authors
- Heurgué, A., Vitry, F., Diebold, M.-D., Yaziji, N., Bernard-Chabert, B., Pennaforte, J.-L., Picot, R., Louvet, H., Frémond, L., Geoffroy, P., Schmit, J.-L., Cadiot, G., & Thiéfin, G.
- Affiliations
- Centre Hospitalier Universitaire de Reims (FR)
- Corresponding author
- Thiéfin, Gérard
- Venue
- Gastroentérologie Clinique et Biologique
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 31
- Issue
- 1
- Pages
- 17-25
- ISSN
- 0399-8320 (ISSN-L)
- OpenAlex
- W2059457551
- Cited by
- 80
- References
- 44
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 1 · 2015: 8 · 2014: 4 · 2013: 6 · 2012: 5
- FWCI
- 2.72
- Type
- journal article
- Language
- fr
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Gastroentérologie Clinique et Biologique (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- overlap syndrome, primary biliary cirrhosis, autoimmune hepatitis, autoimmune liver disease, ursodeoxycholic acid, immunosuppressive therapy, corticosteroids, azathioprine, cyclosporine, piecemeal necrosis, treatment response, histopathology, serum biomarkers, age and sex differences, jaundice
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Cholagogues and Choleretics, Drug Therapy, Combination, Female, France, Humans, Immunosuppressive Agents, Liver, Liver Cirrhosis, Biliary, Liver Function Tests, Male, Medical Records, Middle Aged, Retrospective Studies, Syndrome, Ursodeoxycholic Acid, Cholangitis, Sclerosing, Treatment Outcome, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. https://app.cochat.ai/papers/10.1016/s0399-8320(07)89323-7
- The paper
- Heurgué, A., Vitry, F., Diebold, M.-D., Yaziji, N., Bernard-Chabert, B., Pennaforte, J.-L., Picot, R., Louvet, H., Frémond, L., Geoffroy, P., Schmit, J.-L., Cadiot, G., & Thiéfin, G. (2007). Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroentérologie Clinique et Biologique. https://doi.org/10.1016/s0399-8320(07)89323-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.